Praxis Precision Medicines
Latest round
- Series C
Last raised
- Jul 2020
Total raised
- $167M
Investors
- 15
About Praxis Precision Medicines
Founded in 2015 by co-founders David Goldstein, Kiran Reddy, and Steven Petrou and based in Massachusetts, US, Praxis Precision Medicines, Inc. researches and develops therapies for neurological disorders. The company utilizes genome sequencing to determine parts of the brain that light up with regard to diseases such as epilepsy, mood disorders, pain syndromes, and movement disorders. In March 2024, Praxis Precision Medicines, Inc.5 apiece on the Nasdaq Global Select Market. In addition, underwriters were granted a 30-day option to purchase up to 530,973 additional shares. The company product pipeline includes several drug candidates in different stages of clinical trials, including PRAX-944 for essential tremor and PRAX-628 for specific types of epilepsy. The cerebrum platform utilizes genetic insights to identify potential drug targets for CNS disorders characterized by imbalances in neuronal excitation and inhibition. Additionally, the solidus platform utilizes antisense oligonucleotide (ASO) technology to regulate the expression of genes linked to CNS disorders.
Who invested in Praxis Precision Medicines
15 investors across 2 rounds
See all investors in Praxis Precision Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Praxis Precision Medicines
Who invested in Praxis Precision Medicines?
Praxis Precision Medicines has 15 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Praxis Precision Medicines raised?
Praxis Precision Medicines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Praxis Precision Medicines last raise money?
Praxis Precision Medicines's most recent round on record is a Series C, in Jul 2020.
What does Praxis Precision Medicines do?
Founded in 2015 by co-founders David Goldstein, Kiran Reddy, and Steven Petrou and based in Massachusetts, US, Praxis Precision Medicines, Inc.
Where is Praxis Precision Medicines headquartered?
Praxis Precision Medicines is headquartered in Cambridge, US.
Which VCs invest in companies like Praxis Precision Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Praxis Precision Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Praxis Precision Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.